CDRH Looks Ahead to Priorities for 2018 to 2022
By Zachary Brennan -
Published 17 January 2018
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) announced Wednesday that it has met its three strategic goals from 2016 and 2017 and it has outlined three more for 2018 to 2022.
Categories: News, US, CDRH, Medical Devices, Regulatory intelligence, Regulatory strategy
Tags: novel devices, UDI, NGS